Biological Sex Differences in Cocaine Response

Naomi Carr
Brittany Ferri
Written by Naomi Carr on 27 January 2026
Medically reviewed by Brittany Ferri on 10 February 2026

New research indicates that males and females could respond differently to the effects of cocaine in the brain. This could have significant implications in the development of addiction and associated behaviors, and how treatments can be tailored to meet individual needs.

Biological Sex Differences in Cocaine Response

Overview of cocaine's effects on the brain

Cocaine activates reward and reinforcement effects on the brain. When cocaine is used, it causes an intense euphoria or ‘high’, and releases a surge of dopamine. Dopamine is highly involved in the brain’s reward center. The dopamine release and euphoric effects of cocaine create a reward effect and a desire to repeat use.

Main study findings: Sex differences in cocaine brain effects revealed

A new study investigated the differences between male and female mice in their brain responses to cocaine.

This study focused on the dopamine D1 receptor-expressing medium spiny neurons (D1R-MSNs) and the dopamine D2 receptor-expressing medium spiny neurons (D2R-MSNs), located in the nucleus accumbens core. The nucleus accumbens core is a part of the brain associated with the regulation of behavioral motivation and the reward circuit.

This study found fundamental differences in the brain responses of male and female mice, with further differences related to the female cycle stages. Advanced technology and methods allowed the researchers to observe neuronal changes. They found that D1R-MSN activity differed between males and females, and that the female cycle could also alter this activity.

How cocaine affects males and females differently

This study indicated that:

  • Without exposure to cocaine, female D1R-MSN activity fluctuates with the cycle, with more excitability in this MSN during estrus (the fertile period) than during diestrus (the luteal phase).
  • This pattern was reversed with cocaine exposure, causing decreased D1R-MSN excitability during the estrus phase and increased excitability during the diestrus phase.
  • D1R-MSN and D2R-MSN activity were unchanged by cocaine in males.
  • D2R-MSN activity was unchanged by cocaine in females.
  • Due to the differences in excitability during the cycle, it may be that progesterone provides a protective factor in females against the effects of cocaine.

Behavioral and clinical impacts

D1R-MSN activity is associated with promoting the reinforcing and rewarding effects that serve to motivate behaviors. The differences in D1R-MSN activity discovered in this study indicate that females may experience significantly different responses to cocaine than males, which can also depend on the stage of their cycle.

This could potentially mean that females experience increased rewarding and reinforcing effects of the drug. As such, there may be sex-specific mechanisms involved in drug use and the development of addiction.

Past research also highlights sex-specific differences in cocaine responses, with similar findings that also suggest a female-specific susceptibility to increased reinforcement and drug use. For example:

Along with these impacts, research shows other behavioral differences between males and females, such as drug-seeking behaviors and underlying causal factors. For example, females may be more likely to use drugs as self-medication to alleviate negative emotions. In contrast, males may be more likely to use drugs recreationally, with the aim of experiencing the euphoric effects.

Tailoring recovery for sex differences

All of these differences highlight the individual factors involved in the development of addiction, including hormones and other sex-related differences, as well as genetic and environmental factors. As such, treatment and recovery processes must take these factors into account to provide individualized care.

Treatment methods could integrate sex-specific differences, such as utilizing a range of approaches and support methods throughout the cycle for females to address the varying needs experienced during different phases.

By developing a greater understanding of the psychological and neurological sex differences, medicinal treatments could be tailored to address sex-specific brain activity. Additionally, relapse prevention plans could be developed that are tailored to the individual and incorporate sex differences in trigger and relapse vulnerability.

Future directions

This study highlights the need for further research into the biological sex differences associated with responses to cocaine and other substances. With a more comprehensive understanding of these differences, substance use disorder treatment can be developed to better address personal impacts and needs, potentially leading to improvements in therapeutic interventions and outcomes.

Resources:

  1. National Institute on Drug Abuse. (2024). Cocaine. NIDA. Retrieved from
  2. Chapp, A.D., McMullan, H.M., Phan, C.H., Jagtap, P.P., & Mermelstein, P.G. (2025). Fundamental Sex Differences in Cocaine-Induced Plasticity of D1R- and D2R-MSNs in the Mouse Nucleus Accumbens Core. bioRxiv: the preprint server for biology, 2025.06.18.660420. Retrieved from
  3. Sex Differences in Cocaine Effects on Nucleus Accumbens. (2025). Bioengineer. Retrieved from
  4. Zhou, Y., Zhao, M., Zhou, C., & Li, R. (2016). Sex Differences in Drug Addiction and Response to Exercise Intervention: From Human to Animal Studies. Frontiers in Neuroendocrinology, 40, 24–41. Retrieved from
  5. Becker, J.B. (2016). Sex Differences in Addiction. Dialogues in Clinical Neuroscience, 18(4), 395–402. Retrieved from
  6. Becker, J.B., Perry, A.N., & Westenbroek, C. (2012). Sex Differences in the Neural Mechanisms Mediating Addiction: A New Synthesis and Hypothesis. Biology of Sex Differences, 3(1), 14. Retrieved from

Activity History - Last updated: 10 February 2026, Published date:


Reviewer

Brittany Ferri

PhD, OTR/L

Brittany Ferri holds a PhD in Integrative Mental Health and is an occupational therapist, health writer, medical reviewer, and book author.

Activity History - Medically Reviewed on 27 January 2026 and last checked on 10 February 2026

Medically reviewed by
Brittany Ferri

Brittany Ferri

PhD, OTR/L

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (833) 840-1202
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

Access State-Specific Provider Directories for detailed information on locating licensed service providers and recovery residences in your area.

For any specific questions please email us at info@recovered.org